Cargando…

Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cells

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated death. Due to rapid progression and metastasis, the long-term survival remains poor for most patients. Thus, it is important to discover and develop novel preventive strategies and therapeutic approaches for HCC. Recent d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zejian, Zhang, Ning, Li, Wenda, Cao, Jun, Zhang, Lei, Chen, Yajin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351393/ https://www.ncbi.nlm.nih.gov/pubmed/28356950 http://dx.doi.org/10.3892/ol.2016.5466

Ejemplares similares

Promoter Hypermethylation of CHODL Contributes to Carcinogenesis and Indicates Poor Survival in Patients with Early-stage Colorectal Cancer
por: Zhang, Xinyue, et al.
Publicado: (2020)

Perspective on automated in vivo drug screening using the chodl mutant zebrafish line
por: Oprişoreanu, Ana-Maria
Publicado: (2022)

The role of circular RNA hsa_circ_0085616 in proliferation and migration of hepatocellular carcinoma cells
por: Li, Wenda, et al.
Publicado: (2019)

Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway
por: Tan, Wenliang, et al.
Publicado: (2017)

TRAF4 Regulates Migration, Invasion, and Epithelial–Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma
por: Liu, Kairui, et al.
Publicado: (2017)

Twist expression promotes migration and invasion in hepatocellular carcinoma
por: Matsuo, Noriyuki, et al.
Publicado: (2009)

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
por: Tan, Wenliang, et al.
Publicado: (2018)

RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells
por: Xie, Changji, et al.
Publicado: (2021)

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection
por: Zhu, Sicong, et al.
Publicado: (2018)

miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression
por: Chen, Xianqing, et al.
Publicado: (2019)

Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells
por: Chen, Xiao-Peng, et al.
Publicado: (2015)

NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression
por: Zheng, Jin, et al.
Publicado: (2011)

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
por: Tan, Wenliang, et al.
Publicado: (2022)

ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways
por: Yao, Zhicheng, et al.
Publicado: (2017)

Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma
por: Han, Fang, et al.
Publicado: (2022)

Dermcidin Enhances the Migration, Invasion, and Metastasis of Hepatocellular Carcinoma Cells In Vitro and In Vivo
por: Qiu, Fanghua, et al.
Publicado: (2022)

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells
por: Huang, Yao, et al.
Publicado: (2021)

Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion
por: Li, Linlin, et al.
Publicado: (2023)

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Guo, Lei, et al.
Publicado: (2016)

CD90 promotes cell migration, viability and sphere-forming ability of hepatocellular carcinoma cells
por: Zhang, Ketao, et al.
Publicado: (2018)

Co-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular Carcinoma
por: Flores-Téllez, Teresita N. J., et al.
Publicado: (2015)

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
por: Zhang, Xiang, et al.
Publicado: (2019)

Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2022)

Leptin Receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7
por: Huang, He, et al.
Publicado: (2021)

Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion
por: Chen, Jintu, et al.
Publicado: (2021)

Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma
por: Jin, Haojie, et al.
Publicado: (2015)

TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10
por: Liu, Zhiyi, et al.
Publicado: (2018)

MiR-124 inhibits the migration and invasion of human hepatocellular carcinoma cells by suppressing integrin αV expression
por: Cai, Qian Qian, et al.
Publicado: (2017)

MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma
por: Deng, Biao, et al.
Publicado: (2016)

FXR1 promotes proliferation, invasion and migration of hepatocellular carcinoma in vitro and in vivo
por: Zhao, Kun, et al.
Publicado: (2022)

NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
por: Zhang, Yi, et al.
Publicado: (2018)

miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion
por: Liu, Yanping, et al.
Publicado: (2017)

miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1
por: Zeng, Yue-Bin, et al.
Publicado: (2016)

3′3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling
por: Li, Wen-Xue, et al.
Publicado: (2015)

Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma
por: Chen, Guolin, et al.
Publicado: (2021)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhu, Sicong, et al.
Publicado: (2019)

BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma
por: Xu, Meng, et al.
Publicado: (2016)

Elongator promotes the migration and invasion of hepatocellular carcinoma cell by the phosphorylation of AKT
por: Xu, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eh91i8hj4f1jt5mm84k2pcn5np